JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2007; 49:1517-1524, doi:10.1016/j.jacc.2006.12.036 (Published online 26 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maioli, M.
Right arrow Articles by Dabizzi, R. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Maioli, M.
Right arrow Articles by Dabizzi, R. P.

Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial)

Mauro Maioli, MD*, Francesco Bellandi, MD, Mario Leoncini, MD, Anna Toso, MD and Roberto Piero Dabizzi, MD

Division of Cardiology, Misericordia e Dolce Hospital, Prato, Italy.


Figure 1
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Flow of Patients Through the Trial

AMI = acute myocardial infarction; CABG = coronary artery bypass grafting; LBBB = left bundle branch block; PCI = percutaneous coronary intervention.

 

Figure 2
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 TIMI Flow and MBG at Basal Angiography

Basal angiography: Thrombolysis In Myocardial Infarction (TIMI) flow (left) and myocardial blush grade (MBG) (right) in the early versus late groups. Both parameters are significantly better in the early abciximab group with a higher percentage of TIMI flow grade 3 and MBG 3 (left: p = 0.001 vs. late group; right: p = 0.028 vs. late group).

 

Figure 3
View larger version (19K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 3 Left Ventricular Function According to Early and Late Abciximab

Left ventricular function according to early (blue bars) and late (red bars) abciximab. Ejection fraction (EF) (left) and wall motion score index (WMSI) (right) at baseline and at 1 month after primary angioplasty, and mean gain in EF and WMSI between the 2 time points. In the early abciximab patients, both functional parameters were significantly better compared with late abciximab patients (left: p = 0.014 vs. late group; right: p = 0.014 vs. late group); in the same patients, the mean gain in EF (left: p = 0.023 vs. late group) and in WMSI (right: p = 0.031 vs. late group) was significantly higher. Error bars indicate SDs of the mean.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.